Design of in vivo studies of bioavailability--biometrical considerations
Pharmacology
.
1972;8(1):44-54.
doi: 10.1159/000136326.
Authors
J E Bearman
,
R B Loewenson
PMID:
4644655
DOI:
10.1159/000136326
No abstract available
Publication types
Clinical Trial
Controlled Clinical Trial
MeSH terms
Animals
Biometry
Biopharmaceutics*
Blood Glucose
Follow-Up Studies
Humans
Models, Biological
Placebos
Research Design*
Substances
Blood Glucose
Placebos